Zdrowie i gospodarka · 19/01/2011
FDA Withdraws ALBAMYCIN Capsule from Sale Due to Safety Concerns
The US Food and Drug Administration has withdrawn ALBAMYCIN (novobiocin sodium) 250mg capsules from sale, citing safety concerns, and will not accept new applications for this medication.